Machine Learning Vaccine Design for Broader Pathogen Coverage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods for selecting candidate vaccine antigens are inadequate in addressing the complexity of modern pathogenic landscapes, particularly with the rise in the number of pathogenic isolates, leading to suboptimal vaccine effectiveness.
Innovation Solution
A system utilizing machine learning models, including recurrent neural networks, to predict molecular sequences that will generate a maximized biological response or effective coverage against multiple pathogenic strains by training driver models on temporal sequence data and validating their predictions through translational axes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional methods are used to select candidate vaccine antigens, then the process is simple and straightforward, but the vaccine effectiveness is suboptimal due to inability to address complexity of modern pathogenic landscapes
Solution Approach 1:
The patent replaces traditional mechanical/manual vaccine selection methods with machine learning models and computational algorithms. The system uses automated computational approaches to predict molecular sequences and evaluate vaccine candidates, substituting human expert analysis with algorithmic processing that can handle complex pathogenic landscape data more effectively.
Solution Approach 2:
The patent changes the parameters of vaccine selection by using machine learning models that evaluate multiple molecular sequence parameters simultaneously. The system predicts biological responses based on temporal sequence data and evaluates candidates across multiple translational axes, transforming the selection criteria from simple antigen presence to complex predictive modeling of immunological responses.
2Adaptability or versatility
If the number of pathogenic isolates increases, then the pathogenic landscape becomes more complex, but traditional selection methods become inadequate and less effective
Solution Approach 1:
The patent applies dynamics by using machine learning models that can adapt to changing pathogenic landscapes. The system processes temporal sequence data and updates predictions based on evolving viral sequences, allowing the vaccine selection process to dynamically respond to increasing pathogen diversity rather than relying on static traditional methods.
Solution Approach 2:
The patent uses computational copying by creating virtual representations of pathogenic strains through molecular sequence data. The machine learning models simulate and predict biological responses to numerous pathogenic isolates without requiring physical testing of each strain, enabling the system to adapt to complex pathogenic landscapes efficiently.
3Reliability
If machine learning models are used to predict molecular sequences, then vaccine effectiveness is improved, but the computational complexity and training requirements increase
Solution Approach 1:
The patent applies preliminary action by pre-training machine learning models on extensive temporal sequence data before actual vaccine candidate evaluation. The models are prepared in advance with learned patterns from historical pathogenic data, enabling them to quickly and accurately predict molecular sequences for new vaccine candidates without requiring complex real-time computations during the selection process.
Solution Approach 2:
The patent uses machine learning models as intermediaries between raw pathogenic sequence data and vaccine candidate evaluation. The models serve as computational mediators that translate complex temporal sequence data into predicted molecular sequences and biological responses, simplifying the overall process despite the underlying computational complexity.
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
A system for designing vaccines includes one or more processors, and computer storage storing executable computer instructions in which, when executed by the one or more processers, cause the one or more processors to perform one or more operations. The one or more operations include applying, to a first temporal sequence data set, a plurality of driver models configured to generate output data representing one or more molecular sequences. The one or more operations include, for each of the plurality of driver models, training the driver model. The one or more operations include selecting, based on one or more trained translational responses, a set of trained driver models of the plurality of driver models. The one or more operations include selecting, based on second translational response data, a subset of trained driver models of the set of trained driver models.